pomalidomide has been researched along with thyroxine in 1 studies
| Studies (pomalidomide) | Trials (pomalidomide) | Recent Studies (post-2010) (pomalidomide) | Studies (thyroxine) | Trials (thyroxine) | Recent Studies (post-2010) (thyroxine) |
|---|---|---|---|---|---|
| 623 | 121 | 552 | 38,989 | 1,410 | 6,550 |
| Protein | Taxonomy | pomalidomide (IC50) | thyroxine (IC50) |
|---|---|---|---|
| Transthyretin | Homo sapiens (human) | 2.1939 | |
| UDP-glucuronosyltransferase 1A1 | Homo sapiens (human) | 5.25 | |
| Solute carrier organic anion transporter family member 4C1 | Homo sapiens (human) | 8 | |
| Bile acid receptor | Homo sapiens (human) | 7.86 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Qureshi, A; Rhee, JH | 1 |
1 other study(ies) available for pomalidomide and thyroxine
| Article | Year |
|---|---|
Hyponatraemia due to hypothyroidism: a rare side effect from pomalidomide.
Topics: Aged; Humans; Hyponatremia; Hypothyroidism; Male; Thalidomide; Thyrotropin; Thyroxine; Triiodothyronine | 2021 |